Introduction of laser technology and procedure use for benign prostatic hyperplasia: data from Florida.

[1]  E. Vicaut,et al.  Photoselective vaporization of the prostate with GreenLight 120-W laser compared with monopolar transurethral resection of the prostate: a multicenter randomized controlled trial. , 2012, European urology.

[2]  L. Pezzin,et al.  The Association of Robotic Surgical Technology and Hospital Prostatectomy volumes , 2012, Cancer.

[3]  Cary P Gross,et al.  The Association Between Diffusion of the Surgical Robot and Radical Prostatectomy Rates , 2011, Medical care.

[4]  S. Krein,et al.  Opening of ambulatory surgery centers and procedure use in elderly patients: data from Florida. , 2011, Archives of surgery.

[5]  A. Zietman,et al.  Technology evolution: is it survival of the fittest? , 2010, Journal of Clinical Oncology.

[6]  J. Birkmeyer,et al.  Opening ambulatory surgery centers and stone surgery rates in health care markets. , 2010, The Journal of urology.

[7]  R. Goeree,et al.  Systematic review and meta-analysis of transurethral resection of the prostate versus minimally invasive procedures for the treatment of benign prostatic obstruction. , 2010, Urology.

[8]  Timothy J Wilt,et al.  Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies. , 2008, The Journal of urology.

[9]  Kevin G Volpp,et al.  Mortality among hospitalized Medicare beneficiaries in the first 2 years following ACGME resident duty hour reform. , 2007, JAMA.

[10]  G. Joyce,et al.  Economic evaluation of treatment strategies for benign prostatic hyperplasia--is medical therapy more costly in the long run? , 2007, The Journal of urology.

[11]  D. Bouchier-Hayes.  Photoselective vaporization of the prostate – towards a new standard , 2007, Prostate Cancer and Prostatic Diseases.

[12]  John T. Wei,et al.  The economics of benign prostatic hyperplasia and lower urinary tract symptoms in the united states , 2006, Current urology reports.

[13]  G. Joyce,et al.  Economic costs of benign prostatic hyperplasia in the private sector. , 2005, The Journal of urology.

[14]  J. Birkmeyer,et al.  Trends in surgery for gastroesophageal reflux disease: the effect of laparoscopic surgery on utilization. , 2003, Surgery.

[15]  E. Giovannucci,et al.  Prevalence of and racial/ethnic variation in lower urinary tract symptoms and noncancer prostate surgery in U.S. men. , 2002, Urology.

[16]  L. Chambless,et al.  Neighborhood of residence and incidence of coronary heart disease. , 2001, The New England journal of medicine.

[17]  Russell S. Kirby,et al.  The Dartmouth Atlas of Health Care , 1998 .

[18]  S. Greenland.  Dose‐Response and Trend Analysis in Epidemiology: Alternatives to Categorical Analysis , 1995, Epidemiology.

[19]  M. Talamini,et al.  Surgical rates and operative mortality for open and laparoscopic cholecystectomy in Maryland. , 1994, The New England journal of medicine.

[20]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[21]  K McPherson,et al.  An assessment of prostatectomy for benign urinary tract obstruction. Geographic variations and the evaluation of medical care outcomes. , 1988, JAMA.

[22]  J. Richardson,et al.  Reconsidering theories and evidence of supplier induced demand , 2006 .

[23]  F. Osterman.  The use of angioplasty, bypass surgery, and amputation in the management of peripheral vascular disease. , 1992, The New England journal of medicine.

[24]  B. Barnes,et al.  Professional uncertainty and the problem of supplier-induced demand. , 1982, Social science & medicine.